Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “hepatocellular carcinoma”
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06750159. IPD Sharing: YES. Countries: 0. Publications: 0.
Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03285867. IPD Sharing: NO. Countries: 0. Publications: 0.
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
ClinicalTrials.gov study NCT03227510. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
ClinicalTrials.gov study NCT02772029. IPD Sharing: NO. Countries: 0. Publications: 0.
Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06512467. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03114085. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization
ClinicalTrials.gov study NCT02552745. IPD Sharing: Not stated. Countries: 0. Publications: 0.
TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria
ClinicalTrials.gov study NCT07268131. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07115550. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04479527. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT03851887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy
ClinicalTrials.gov study NCT03235167. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05903456. IPD Sharing: NO. Countries: 0. Publications: 0.
Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Conti
ClinicalTrials.gov study NCT07206511. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03985644. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03066557. IPD Sharing: YES. Countries: 0. Publications: 0.
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02025842. IPD Sharing: Not stated. Countries: 0. Publications: 0.
AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
ClinicalTrials.gov study NCT05578430. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Vir
ClinicalTrials.gov study NCT06872047. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load
ClinicalTrials.gov study NCT02308319. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.